2023-05-03 13:37:49 ET
- Regeneron Pharmaceuticals ( NASDAQ: REGN ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open.
- The consensus EPS Estimate is $9.56 (-16.8% Y/Y) and the consensus Revenue Estimate is $3B (+1.0% Y/Y).
- Over the last 2 years, REGN has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 7 downward. Revenue estimates have seen 7 upward revisions and 3 downward.
For further details see:
Regeneron Pharmaceuticals Q1 2023 Earnings Preview